Washington University investigators at Siteman Cancer Center at Barnes-Jewish Hospital
Researchers make immunotherapy work for treatment-resistant lymphoma: Transplanting T-cells boosts efficacy of immunotherapies in several cancers
Mount Sinai researchers have developed a way to use immunotherapy
Drug combo heralds major shift in chronic lymphocytic leukemia treatment
A combination of two drugs keeps patients with chronic lymphocytic
Researchers discover therapy to treat drug-resistant acute lymphoblastic leukemia
Acute lymphoblastic leukemia accounts for one in five adult leukemias,
Sports playbook helps doctors predict cancer patient outcomes
In this season of global soccer competitions and hotly contested
A young mother with leukemia: a 28-Year-old urgently needs a stem cell donor
Blood cancer is a difficult-to-treat Form of cancer. The chances
Blood cancer’s Achilles’ heel opens door for new treatments
New findings about a fatal form of blood cancer could
The Leukemia Atlas: researchers unveil proteins that signal disease
Only about one in four people diagnosed with acute myelogenous
Loss of a DNA repair system creates a unique vulnerability in many cancer types: Cancer cells that cannot repair a certain form of DNA mutation become strongly dependent on single enzyme to survive, creating a new potential opportunity for drug development
Cancer cells adapt to potentially fatal mutations and other molecular
Gilteritinib improves survival for patients with acute myeloid leukemia
Treatment with the FLT3-targeted therapeutic gilteritinib (Xospata) improved survival for